The human retinal pigment epithelial cell line ARPE19 (ATCC, CRL-2302) was used for the propagation of the VZVeGFP-ORF23 strain, as previously described (25, 28). In this pOka-derived recombinant VZV strain, the minor capsid protein ORF23 is fused with the enhanced green fluorescent protein (eGFP). Following VZVeGFP-ORF23 propagation in ARPE19 cells, infected cells were harvested and cryopreserved in 900µL cARPE19 medium [90% DMEM/F12 (Gibco, 11320-074) + 10% FBS (Gibco, 10270-106)] + 100µL DMSO (Sigma, D2650) at a concentration of 1.0 x 106 cells per vial. After thawing, VZVeGFP-ORF23 titres in plaque-forming units (PFU) were determined using an infectious foci assay in ARPE19 cells, according to previously described procedures (25, 28, 29).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.